163 related articles for article (PubMed ID: 1341460)
1. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues.
Mårin P; Krotkiewski M; Björntorp P
Eur J Med; 1992 Oct; 1(6):329-36. PubMed ID: 1341460
[TBL] [Abstract][Full Text] [Related]
2. Physical training in the prophylaxis and treatment of obesity, hypertension and diabetes.
Krotkiewski M
Scand J Rehabil Med Suppl; 1983; 9():55-70. PubMed ID: 6372078
[TBL] [Abstract][Full Text] [Related]
3. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
[TBL] [Abstract][Full Text] [Related]
4. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
[TBL] [Abstract][Full Text] [Related]
5. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.
Krotkiewski M; Björntorp P; Sjöström L; Smith U
J Clin Invest; 1983 Sep; 72(3):1150-62. PubMed ID: 6350364
[TBL] [Abstract][Full Text] [Related]
6. Weight loss in obese men by caloric restriction and high-dose diazoxide-mediated insulin suppression.
van Boekel G; Loves S; van Sorge A; Ruinemans-Koerts J; Rijnders T; de Boer H
Diabetes Obes Metab; 2008 Dec; 10(12):1195-203. PubMed ID: 18476985
[TBL] [Abstract][Full Text] [Related]
7. Muscle tissue in obesity with different distribution of adipose tissue. Effects of physical training.
Krotkiewski M; Björntorp P
Int J Obes; 1986; 10(4):331-41. PubMed ID: 3533812
[TBL] [Abstract][Full Text] [Related]
8. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
11. Testosterone, body composition and aging.
Vermeulen A; Goemaere S; Kaufman JM
J Endocrinol Invest; 1999; 22(5 Suppl):110-6. PubMed ID: 10442580
[TBL] [Abstract][Full Text] [Related]
12. Transdermal dihydrotestosterone treatment of 'andropause'.
de Lignieres B
Ann Med; 1993 Jun; 25(3):235-41. PubMed ID: 7687444
[TBL] [Abstract][Full Text] [Related]
13. Effect of testosterone on abdominal adipose tissue in men.
Rebuffé-Scrive M; Mårin P; Björntorp P
Int J Obes; 1991 Nov; 15(11):791-5. PubMed ID: 1778664
[TBL] [Abstract][Full Text] [Related]
14. Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.
Juang PS; Peng S; Allehmazedeh K; Shah A; Coviello AD; Herbst KL
J Sex Med; 2014 Feb; 11(2):563-73. PubMed ID: 24344872
[TBL] [Abstract][Full Text] [Related]
15. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
Mårin P; Holmäng S; Jönsson L; Sjöström L; Kvist H; Holm G; Lindstedt G; Björntorp P
Int J Obes Relat Metab Disord; 1992 Dec; 16(12):991-7. PubMed ID: 1335979
[TBL] [Abstract][Full Text] [Related]
16. Glucose tolerance and insulin response to glucose load in body builders.
Szczypaczewska M; Nazar K; Kaciuba-Uscilko H
Int J Sports Med; 1989 Feb; 10(1):34-7. PubMed ID: 2649445
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
Idan A; Griffiths KA; Harwood DT; Seibel MJ; Turner L; Conway AJ; Handelsman DJ
Ann Intern Med; 2010 Nov; 153(10):621-32. PubMed ID: 21079217
[TBL] [Abstract][Full Text] [Related]
18. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Berman N; Hull L; Swerdloff RS
J Clin Endocrinol Metab; 2004 May; 89(5):2085-98. PubMed ID: 15126525
[TBL] [Abstract][Full Text] [Related]
19. The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men.
Pospíšilová H; Vaňková M; Hill M; Meloun M; Bendlová B; Dušková M; Stárka L
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):105-11. PubMed ID: 22421634
[TBL] [Abstract][Full Text] [Related]
20. Androgen treatment of abdominally obese men.
Mårin P; Holmäng S; Gustafsson C; Jönsson L; Kvist H; Elander A; Eldh J; Sjöström L; Holm G; Björntorp P
Obes Res; 1993 Jul; 1(4):245-51. PubMed ID: 16350577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
